Global Amifostine Market Growth 2025-2031

The global Amifostine market size is predicted to grow from US$ 51 million in 2025 to US$ 58 million in 2031; it is expected to grow at a CAGR of 2.2% from 2025 to 2031.

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol.

Global Amifostine key players include Sun Pharmaceutical, Clinigen Group, Merro Pharmaceutical, Taj Pharmaceuticals, Luye Pharma, etc. Global top five manufacturers hold a share over 90%. North America is the largest sales market, with a share over 50%, followed by Asia-Pacific with a share over 40 percent.

LP Information, Inc. (LPI) ' newest research report, the “Amifostine Industry Forecast” looks at past sales and reviews total world Amifostine sales in 2024, providing a comprehensive analysis by region and market sector of projected Amifostine sales for 2025 through 2031. With Amifostine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amifostine industry.

This Insight Report provides a comprehensive analysis of the global Amifostine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amifostine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amifostine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amifostine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amifostine.

This report presents a comprehensive overview, market shares, and growth opportunities of Amifostine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
400mg/Dose
500mg/Dose

Segmentation by Application:
Head and Neck Cancer Adjuvant Therapy
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Clinigen
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Amifostine market?

What factors are driving Amifostine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Amifostine market opportunities vary by end market size?

How does Amifostine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.